Prophylactic Use of Noninvasive Ventilation in the Postoperative Period of Bariatric Surgery
1 other identifier
interventional
31
1 country
1
Brief Summary
Comorbidities associated with severe obesity determine an important public health problem. Few methods are considered potentially effective for the treatment of severe obesity and the clinical relevance of bariatric surgery is growing, as well as the number of procedures performed. The insertion of the physiotherapist in the multiprofessional team responsible for performing the surgical procedure is essential from the preoperative screening and evaluation to the prevention and treatment of postoperative complications. Therefore, the physiopathological aspects involved with severe obesity, the technical aspects and risks of the surgical procedure, as well as the physiotherapeutic techniques that have scientific proof must be known by the physiotherapist responsible for the surgical follow-up of the patient. In this context, the use of non-invasive ventilation (NIV) in the postoperative period of bariatric surgery has ample therapeutic potential. The present research project aims to evaluate the immediate prophylactic use of NIV on the respiratory and functional recovery of the patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2018
CompletedFirst Submitted
Initial submission to the registry
November 3, 2020
CompletedFirst Posted
Study publicly available on registry
March 18, 2021
CompletedMarch 18, 2021
March 1, 2021
1.2 years
November 3, 2020
March 17, 2021
Conditions
Outcome Measures
Primary Outcomes (12)
Forced Vital Capacity (FVC)
Larger volume of air mobilized on an exhalation.
Preoperative
Forced Vital Capacity (FVC)
Larger volume of air mobilized on an exhalation.
10 minutes after admission to the recovery room
Forced Vital Capacity (FVC)
Larger volume of air mobilized on an exhalation.
1 hour after admission to the recovery room
Forced expiratory volume in one second (FEV1)
Volume of air exhaled in the first second during the FVC maneuver.
Preoperative
Forced expiratory volume in one second (FEV1)
Volume of air exhaled in the first second during the FVC maneuver.
10 minutes after admission to the recovery room
Forced expiratory volume in one second (FEV1)
Volume of air exhaled in the first second during the FVC maneuver.
1 hour after admission to the recovery room
FEV1/FVC ratio
Ratio between forced expiratory volume in the first second and vital capacity.
Preoperative
FEV1/FVC ratio
Ratio between forced expiratory volume in the first second and vital capacity.
10 minutes after admission to the recovery room
FEV1/FVC ratio
Ratio between forced expiratory volume in the first second and vital capacity.
1 hour after admission to the recovery room
Peak expiratory flow (PEF)
Maximum air flow during the FVC maneuver.
Preoperative
Peak expiratory flow (PEF)
Maximum air flow during the FVC maneuver.
10 minutes after admission to the recovery room
Peak expiratory flow (PEF)
Maximum air flow during the FVC maneuver.
1 hour after admission to the recovery room
Study Arms (2)
Non invasive mechanical ventilation
EXPERIMENTALThe subjects in the immediate intervention group (GI) will be extubated and placed in NIV the moment they enter the recovery room through a portable ventilator (Esprit ® or BiPAP Vision ®, Respironics) in face mask. The parameters will be adjusted as follows: FiO2 = 50%, positive expiratory pressure (EPAP, starting at 4-6 cmH2O and adjusting 1-2 cmH2O to avoid snoring, apnea, paradoxical breathing and desaturations) and adjusted inspiratory positive pressure (IPAP) to maintain a tidal volume of 400 to 500 ml, maintaining IPAP \<15cmH2O17. Individuals will receive this ventilatory support for 1 hour. After this period the patients will be submitted to the same care of GP patients.
Usual care
ACTIVE COMPARATORSubjects will receive oxygen therapy through a nasal cannula with 4 to 6 L / min of oxygen according to the team routine and patient need.
Interventions
Prophylactic non invasive mechanical ventilation
GP subjects will receive oxygen therapy through a nasal cannula with 4 to 6 L / min of oxygen according to team routine and patient need.
Eligibility Criteria
You may qualify if:
- Adult patients undergoing bariatric surgery
You may not qualify if:
- Absolute or relative contraindications to the use of NIV
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fábio Di Naso, PhD
Federal University of Rio Grande do Sul
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2020
First Posted
March 18, 2021
Study Start
March 1, 2017
Primary Completion
May 31, 2018
Study Completion
July 31, 2018
Last Updated
March 18, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share